Pure methoxycarbonylsulfenyl cyanide, CH(3)OC(O)SCN (I), and methoxycarbonylsulfenyl thiocyanate, CH(3)OC(O)SSCN (II), were prepared by reacting liquid CH(3)OC(O)SCl with either AgCN or AgSCN, respectively. Compounds I and II were characterized by (1)H NMR, CG-MS, and vibrational (FTIR and FT-Raman) techniques. The conformational properties have been studied by using vibrational spectroscopy [infrared (gaseous, liquid, and Ar matrix isolated), Raman (liquid) spectroscopy] together with quantum chemical calculations at the B3LYP and MP2 methods with the extended 6-311++G** and aug-cc-pVTZ basis sets. Compound I exhibits a conformational equilibrium at room temperature having the most stable form C(s) symmetry with a synperiplanar (syn) orientation of the carbonyl double bond (C=O) with respect to both the CH(3)O- and -SCN groups (syn-syn). Several bands assigned to a second conformer have been observed in the IR matrix spectra. This rotamer presents an antiperiplanar orientation of the thiocyanate group (syn-anti). Evaluating the equilibrium compositions at different temperatures by quenching the gas phase mixtures as Ar matrices allowed us to determine the conformational enthalpy difference DeltaH(0) = H(0)((syn-anti)) - H(0)((syn-syn)) = 0.80(18) kcal mol(-1). A similar conformational behavior has been determined for compound II. Thermodynamic properties were also computed at the high-level G2MP2 and G3 model chemistry methods. The importance of mesomeric (resonance) and anomeric (hyperconjugation) electronic interaction in the conformational behavior is evaluated by using the NBO approach for both species.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.